Zinzani P.L.;Pellegrini C.;Merla E.;Ballerini F.;Fabbri A.; Guarini A.;Pavone V.;Quintini G.;Puccini B.;Vigliotti M.L.; Stefoni V.; Derenzini E.;Broccoli A.;Gandolfi L.;Quirini F.;Casadei B.;Argnani L.;Baccarani M., Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study, «HEMATOLOGICAL ONCOLOGY», 2013, 31, pp. 179 - 182 [articolo]
Zinzani PL;Viviani S;Anastasia A;Vitolo U;Luminari S;Zaja F;Corradini P;Spina M;Brusamolino E;Gianni AM;Santoro A;Botto B;Derenzini E;Pellegrini C;Argnani L, Brentuximab vedotin in relapsed/refractory Hodgkin's lymphoma: the Italian experience and results of its use in daily clinical practice outside clinical trials., «HAEMATOLOGICA», 2013, 98, pp. 1232 - 1236 [articolo]Open Access
Derenzini E; Stefoni V; Maglie R; Casadei B; Pellegrini C; Broccoli A; Stefani G; Fanti S; Motta MR; Narducci R; Argnani L; Zinzani PL., Collection of Hematopoietic Stem Cells after Previous Radioimmunotherapy is Feasible and Does Not Impair Engraftment after Autologous Stem Cell Transplantation in Follicular Lymphoma., «BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION», 2013, 19, pp. 1695 - 1701 [articolo]
Broccoli A;Derenzini E;Pellegrini C;Narducci R;Stefani G;Casadei B;Argnani L;Zinzani PL, Complete response of relapsed systemic and cutaneous anaplastic large cell lymphoma using brentuximab vedotin: 2 case reports., «CLINICAL LYMPHOMA MYELOMA & LEUKEMIA», 2013, 13, pp. 493 - 495 [articolo]
Zinzani PL; Pellegrini C; Gandolfi L; Casadei B; Derenzini E; Broccoli A; Quirini F; Argnani L; Pileri S; Celli M; Fanti S; Poletti V; Stefoni V; Baccarani M., Extranodal marginal zone B-cell lymphoma of the lung: experience with fludarabine and mitoxantrone-containing regimens., «HEMATOLOGICAL ONCOLOGY», 2013, 31, pp. 183 - 188 [articolo]
Zinzani PL;Pellegrini C;Broccoli A;Casadei B;Argnani L;Pileri S, Fludarabine-mitoxantrone-rituximab regimen in untreated intermediate/high-risk follicular non-Hodgkin's lymphoma: experience on 142 patients., «AMERICAN JOURNAL OF HEMATOLOGY», 2013, 88, pp. 273 - 276 [articolo]
Zinzani PL;Pellegrini C;Derenzini E;Argnani L;Pileri S, Long-term efficacy of the combination of lenalidomide and rituximab in elderly relapsed/refractory diffuse large B-cell lymphoma patients., «HEMATOLOGICAL ONCOLOGY», 2013, 31, pp. 223 - 224 [articolo]
Derenzini E;Casadei B;Pellegrini C;Argnani L;Pileri S;Zinzani PL, Non-hodgkin lymphomas presenting as soft tissue masses: a single center experience and meta-analysis of the published series., «CLINICAL LYMPHOMA MYELOMA & LEUKEMIA», 2013, 13, pp. 258 - 265 [articolo]
Gandolfi L;Stefani G;Narducci R;Argnani L;Polito E;Zinzani PL, Primary ocular adnexal lymphomas: a retrospective study of 25 patients., «LEUKEMIA & LYMPHOMA», 2013, 54, pp. 4644 - 4644 [articolo]
Pastorelli F;Derenzini E;Plasmati R;Pellegrini C;Broccoli A;Casadei B;Argnani L;Salvi F;Pileri S;Zinzani PL, Severe peripheral motor neuropathy in a patient with Hodgkin lymphoma treated with brentuximab vedotin., «LEUKEMIA & LYMPHOMA», 2013, 54, pp. 2318 - 2321 [articolo]
Zinzani P.L.; Tani M.; Pulsoni A.; De Renzo A.; Stefoni V.; Broccoli A.; Montini G.C.; Fina M.; Pellegrini C.; Gandolfi L.; Cavalieri E.; Torelli F.; Scopinaro F.; Argnani L.; Quirini F.; Derenzini E.; Rossi M.; Pileri S.; Fanti S.; Baccarani M., A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by 90Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma., «ANNALS OF ONCOLOGY», 2012, 23, pp. 415 - 420 [articolo]
Zinzani P.L.; Rigacci L.; Stefoni V.; Broccoli A.; Puccini B.; Castagnoli A.; Vaggelli L.; Zanoni L.; Argnani L.; Baccarani M.; Fanti S., Early interim 18F-FDG PET in Hodgkin's lymphoma: evaluation on 304 patients., «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2012, 39, pp. 4 - 12 [articolo]
Zinzani PL; Bonifazi F; Pellegrini C; Casadei B; Argnani L; Motta MR; Dan E; Stanzani M; Arpinati M; Bandini G., Hairy Cell Leukemia: Allogeneic Transplantation Could be an Optimal Option in Selected Patients., «CLINICAL LYMPHOMA MYELOMA & LEUKEMIA», 2012, 12, pp. 287 - 289 [articolo]
Zinzani PL; Derenzini E; Pellegrini C; Rigacci L; Fabbri A; Gandolfi L;
Argnani L; Casadei B; Pulsoni A; Gobbi M; Perotti A; Zaccaria A; Voso MT; Cabras MG; De Renzo A., Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma)., «ANNALS OF ONCOLOGY», 2012, 23, pp. 805 - 807 [articolo]
Salaffi F, Scirè C, Monti C, Argnani L., Metodologia della Ricerca Clinica ed Epidemiologica. Guida pratica per il reumatologo., Parma, Mattioli 1885 Editore, 2012, pp. 135 . [libro]
